A Phase III clinical trial led by Neeraj Agarwal, MD, FASCO, senior director of clinical research at Huntsman Cancer ...

By Sneha S K May 31 (Reuters) - Johnson & Johnson's prostate cancer drug Erleada used with hormone-blocking therapy six ...

Thousands of men with advanced prostate cancer could soon live longer thanks to a treatment which cuts the risk of the ...

Radical prostatectomy is potentially curative in patients with high-risk localized or locally advanced prostate cancer; however, relapse occurs within 5 years in up to 50% of patients. We ...

There may be a "promising new strategy" in combating aggressive forms of prostate cancer, according to a new study. Researchers at Flinders University and the University of South Australia ...

A novel theranostic approach that targets RET -- a newly identified biomarker for neuroendocrine prostate cancer enables high ...

A drug that has long been used to treat two common men’s health conditions could have some unexpected benefits. Finasteride — more commonly known as Propecia or Proscar — has treated male pattern ...

UVA Health Prince William Medical Center has begun offering Aquablation therapy, an advanced AI-powered treatment for benign ...

Relief for men experiencing the challenges of Benign Prostatic Hyperplasia (BPH), or prostate enlargement, has arrived with the introduction of Flowel and Flowel Plus by Superior Pharmaceuticals ...

Add Yahoo as a preferred source to see more of our stories on Google. Certain prostate medications might help reduce the risk of Lewy body dementia, a specific type of dementia, a new study suggests.

The Health Secretary has confirmed that thousands more Black men will be invited to participate in a prostate cancer ...